MannKind

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.

About MNKD

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.

CEO

Michael E. Castagna

CEOMichael E. Castagna

Employees

407

Employees407

Headquarters

Danbury, Connecticut

HeadquartersDanbury, Connecticut

Founded

1991

Founded1991

Employees

407

Employees407

MNKD Key Statistics

Market cap

1.09B

Market cap1.09B

Price-Earnings ratio

36.11

Price-Earnings ratio36.11

Dividend yield

—

Dividend yield—

Average volume

4.25M

Average volume4.25M

High today

$3.69

High today$3.69

Low today

$3.55

Low today$3.55

Open price

$3.68

Open price$3.68

Volume

1.74M

Volume1.74M

52 Week high

$7.63

52 Week high$7.63

52 Week low

$3.52

52 Week low$3.52

MNKD News

Simply Wall St 19h

Possible Bearish Signals With MannKind Insiders Disposing Stock

Many MannKind Corporation ( ) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. Knowing whether insiders...

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own MNKD. This list is generated using Robinhood data, and it’s not a recommendation.